Drug companies raised prices faster than inflation for about half of all drugs covered by Medicare between July 2019 and July 2020, according to an analysis released last week by the Kaiser Family Foundation. The median price increase was 5.6% for drugs covered by Medicare Part D and 5.4% for drugs covered by Part B, compared with a 1% inflation rate over the period. According to the Campaign for Sustainable Rx Pricing, whose founding members include the AHA, leading drug companies also reported massive profits in fourth-quarter 2021.

Related News Articles

Headline
The Consumer Price Index has climbed 8.6% over the past 12 months before seasonal adjustment, the fastest increase in over 40 years, the Bureau of Labor…
Headline
Launch prices for new brand-name prescription drugs increased 20% per year between 2008 and 2021, according to a study reported yesterday in JAMA. Median…
Headline
In a statement submitted to the Senate Finance Committee for a hearing yesterday on lowering drug prices in Medicare, AHA encouraged Congress to implement…
News
The Centers for Medicare & Medicaid Services Dec. 29 formally rescinded its Most Favored Nation model for Part B drugs. The model was established via…
Headline
The administration yesterday issued an interim final rule requiring health plans to begin submitting annual information next year on prescription drug…
Headline
In addition to being based on a very small sample size, a recently published study on hospital costs for clinician-administered drugs under Medicare Part B…